PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498732
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498732
Intermittent pneumatic Compression (IPC) Devices Market size was valued at USD 1,650.23 million in 2023, expanding at a CAGR of 9.21% from 2024 to 2032.
The Intermittent Pneumatic Compression (IPC) Devices market, which encompasses medical devices designed to improve blood flow and reduce the risk of deep vein thrombosis and other circulatory disorders through controlled pressure application, is experiencing significant growth. The rising prevalence of chronic venous diseases, increasing post-operative recovery demands, and growing awareness of non-invasive treatment options are driving factors. However, market growth is restrained by high device costs, reimbursement challenges, and limited adoption in emerging economies. Opportunities abound in technological advancements, expanding applications in sports and wellness, and increasing healthcare investments in developing regions.
Intermittent pneumatic Compression (IPC) Devices Market- Market Dynamics
IPC Devices' Role Expands with Rising Chronic Condition Incidence
The incidence of chronic conditions is on the rise globally, with organizations such as the World Health Organization (WHO) reporting alarming trends. According to the WHO, chronic diseases account for approximately 60% of all deaths worldwide, with cardiovascular diseases, cancer, respiratory diseases, and diabetes being the leading causes. In the United States alone, the Centers for Disease Control and Prevention (CDC) highlights that nearly six in ten adults have a chronic disease, and four in ten adults have two or more chronic diseases. Moreover, the prevalence of chronic conditions is expected to increase further due to factors such as aging populations, sedentary lifestyles, and unhealthy dietary habits. As a result, there is a growing need for effective management and prevention strategies, including the utilization of medical devices like Intermittent Pneumatic Compression (IPC) Devices to address circulatory issues associated with chronic conditions.
Intermittent pneumatic Compression (IPC) Devices Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.21% over the forecast period (2024-2032)
Based on product type segmentation, Portable IPC Devices were predicted to show maximum market share in the year 2023
Based on application segmentation, Deep Vein Thrombosis (DVT) was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Intermittent Pneumatic Compression (IPC) Devices Market is segmented on the basis of Product Type, Application, End-User, and Region.
The market is divided into three categories based on product type: Portable IPC Devices, Non-portable IPC Devices, and Garments. Portable IPC devices lead the market segment due to their convenience and suitability for home use, offering patients greater flexibility in managing circulatory conditions. Non-portable IPC devices follow, favored in clinical settings for their advanced features. Garments, providing targeted compression, complete the product range.
The market is divided into four categories based on application: Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Lymphedema Management, and Chronic Venous Insufficiency. Deep Vein Thrombosis (DVT) applications dominate the market, driven by the high incidence of this condition and the efficacy of IPC devices in its prevention and treatment. Pulmonary Embolism (PE) and Lymphedema Management follow closely, addressing critical medical needs, while Chronic Venous Insufficiency applications contribute steadily.
Intermittent pneumatic Compression (IPC) Devices Market- Geographical Insights
Developed regions such as North America and Europe dominate the market due to well-established healthcare infrastructure, higher healthcare spending, and greater awareness of advanced medical technologies. In North America, the United States holds a significant share of the market, driven by the presence of key market players and favorable reimbursement policies. Europe, particularly countries like Germany and the United Kingdom, also contributes substantially to market growth, supported by increasing investments in healthcare and a growing geriatric population. Emerging economies in Asia Pacific, Latin America, and the Middle East, and Africa are witnessing rapid market expansion due to improving healthcare access, rising disposable incomes, and growing awareness of preventive healthcare measures. However, market growth in these regions is hindered by challenges such as limited access to advanced healthcare facilities, regulatory hurdles, and affordability issues.
Leading companies such as DJO Global, Inc., Bio Compression Systems, Inc., and BSN Medical GmbH are focusing on research and development activities to introduce advanced IPC devices with improved efficacy and patient comfort. Moreover, strategic collaborations with healthcare providers and distributors enable these companies to enhance their market presence and expand their customer base globally. Additionally, mergers and acquisitions play a crucial role in shaping the competitive landscape, with companies aiming to consolidate their market position and diversify their product portfolios. One instance in the Intermittent Pneumatic Compression (IPC) Devices market is the collaboration between DJO Global, Inc. and a leading healthcare provider to integrate their IPC technology into the provider's post-operative care protocols. The market also witnesses the presence of numerous small and medium-sized enterprises (SMEs) that focus on niche segments or regional markets, contributing to market diversity and fostering innovation.
In March 2022, Fist Assist Devices LLC introduced the Fist Assist Model FA-1, a patented wearable arm compression device designed to promote vein dilation. It's the first of its kind globally, automating pressure applications for ease of use and reducing user error, enhancing blood flow and vein dilation pre-surgery.
In March 2021, Direct Healthcare Group Ltd. acquired Talley Group Ltd, specializing in pressure care products. This strategic move aims to enrich Direct Healthcare Group's portfolio for immobile patients by integrating Talley Group's deep vein thrombosis prophylaxis intermittent pneumatic compression systems.
GLOBAL INTERMITTENT PNEUMATIC COMPRESSION (IPC) DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Arjo AB
Bio Compression Systems, Inc.
BTL Industries, Inc.
Cardinal Health, Inc.
DeRoyal Industries, Inc.
Devon Medical Products
DJO Global, Inc.
FlowAid Medical Technologies Corp.
Kohla GmbH
Medline Industries, LP
Mego Afek Ltd.
Normatec Industries, LP
Tactile Systems Technology, Inc.
Talley Group Ltd.
ThermoTek, Inc.
Zimmer Biomet Holdings, Inc.
Others